298
4–5%. The early detection of high malignant transformation in
OPMD patients is very import.
Methods:
Paired oral cancer/OPMD surgical specimens were
obtained. Gene analysis of exomes was done by next generation
sequencing, (NGS).
Results:
The gene mutation rate was increased in the progression
of OPMD to oral cancer. The chromosome 4 and 17 had more
mutations in oral cancer specimens. Positive correlation of gene
mutation and malignant transformation of OPMD was found.
Conclusion:
Gene mutation was increased in the transformation
of OPMD to oral cancer. Our study might be useful to develop
chemical prevention agent to prevent malignant transformation in
oral pre-cancer lesions.
http://dx.doi.org/10.1016/j.ijom.2017.02.1001Clinicopathological characteristics and outcomes of
squamous cell carcinoma of the tongue in different age
groups
Y.Y. Zhang
∗
, D.C. Wang, J.Z. Su, L.F. Jia, X. Peng, G.Y. Yu
Peking University School and Hospital of Stomatology, China
Background:
The clinicopathological features and outcomes of
squamous cell carcinoma (SCC) of the tongue in patients of dif-
ferent age groups remain debatable.
Objectives:
To evaluate biological behaviours and outcomes of
tongue SCC in different age groups.
Methods:
Medical records of 457 patients with tongue SCC were
reviewed, grouped by age, and followed up. The clinicopatholog-
ical features of the tumours and patients’ outcomes in different
age groups were compared.
Findings and conclusion:
Gender, TNM stage, disease-free sur-
vival (DFS), and disease-specific survival (DSS) showed no
inter-group differences. Patients aged 46–59 years had the most
severe smoking and drinking habits (42.9% and 35.3%, respec-
tively). Tongue SCC in patients’
≤
30 years had the most advanced
TNM stage and the greatest proportion of poorly differentiated
tumours. The death rate caused by recurrence or metastasis in
the youngest group was much higher than the other two groups
(91.7% versus 75.4% and 77.4%, respectively). Young patients
had higher incidence of distant metastasis and recurrence death
rate than middle-aged and oldest patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.1002Brown tumour of the mandible: report of two cases and
review of the literature
H.X. Zou
∗
, J. Jia, Y.F. Zhao
Wuhan University, Wuhan, China
Objectives:
Brown tumours are non-neoplastic lesions resulting
from abnormal bone metabolism in hyperparathyroidism. The
mandible involvement is exceptional, we describe such two cases
and highlight the importance of taking a comprehensive history
and focusing the investigations so that appropriate treatment can
be given.
Methods:
A retrospective analysis of two cases of mandibular
brown tumour patients in our hospital, one case occurred in the
anterior portion of the mandible, another case occurred in the
maxilla and mandible involved femur, ribs and skull. The clinical
features, laboratory investigations, pathological characteristics,
imaging findings and treatment were retrospectively analysed.
Findings:
Both patients showed weight loss, fatigue, anorexia,
nausea, pain and decreased bone density, high levels of serum cal-
cium, alkaline phosphatase, urinary calcium, parathyroid hormone
and lower levels of serum phosphorus and urinary calculi history,
X-ray showed decreased bone density, extensive fibrosis, cys-
tic degeneration. Histopathological examination showed a lesion
with newly formed bone tissue, diffuse giant cells and deposits of
haemosiderin in a background of fibrovascular proliferation.
Conclusion:
The diagnosis of mandibular brown tumour was
suggested by the clinical history and confirmed by labo-
ratory investigations including calcium, phosphorus, alkaline
phosphatase, parathormone assays, computed tomography and
histopathological determinations. For mandibular cystic lesions
associated with urinary tract stones, hypercalcaemia, osteoporo-
sis, brown tumours should be highly suspected. A majority of
these lesions may disappear with the removal of the parathyroid
pathology.
http://dx.doi.org/10.1016/j.ijom.2017.02.1003Oral and Maxillofacial Pathology
Enucleation with adjuvant therapy as treatment modality for
ameloblastoma — a retrospective analysis of 10 years
A. Akare
∗
, A. Datarkar, P. Pandilwar
Government Dental College and Hospital, Nagpur, India
Background:
Ameloblastoma is a rare odontogenic neoplasm of
the mandible and maxilla, with multiple histologic variants, and
high recurrence rates if improperly treated. Historically, the extent
of resection has been controversial, comprising of two surgical
options: ‘conservative’ versus ‘radical’.
Objective:
The aim of this presentation is to retrospectively eval-
uate the patients with ameloblastoma treated in our department
with enucleation and adjuvant therapy followed for 10 years.
Methods:
A retrospective study was done in the Department of
Oral and Maxillofacial Surgery, Government Dental College and
Hospital, Nagpur. The demographic data was collected retrospec-
tively from89 patients, and clinical and radiographic features were
carefully documented. Type of ameloblastoma, size and site of
lesion, sufficient amount of remaining healthy bone, and the type
of treatment, received conservative as enucleation, along with or
without adjuvant therapy or radical resection were studied.
Result:
Total of 89 patients presented to the department with
pathology, of whom 39 patients (mean age, 30 years) were
diagnosed as Ameloblastoma and included in the study. Radio-
graphically shows unilocular and multilocular radiolucency,
histologically reported unicystic/mural ameloblastoma or plex-
iform ameloblastoma were treated by enucleation along with
adjuvant therapy and under follow-up for past 10 years.
Conclusion:
Therapeutically, simple enucleation has no role in
the management of ameloblastoma but the study concluded that
enucleation along with the adjuvant therapy has played impor-
tant role in treating ameloblastoma perhaps the unicystic subtype.
Advantages of enucleation include the fact that it requires no
reconstruction.
http://dx.doi.org/10.1016/j.ijom.2017.02.1004




